M. Baekelandt

The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian Cancer

Amin Makar, M. Baekelandt, Claes O. Tropé et al. · Gynecologic Oncology · 1995 · 223 citations

Residual Disease, Tumoral Pathology, Medicine +10

Carcinoma of the fallopian tube

M. Baekelandt, Anne Jorunn Nesbakken, Gunnar B. Kristensen et al. · Cancer · 2000 · 190 citations

Surgical Oncology, Tumoral Pathology, Early Stage +12

Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Catherine Lhommé, Florence Joly, Joan L. Walker et al. · Journal of Clinical Oncology · 2008 · 154 citations · Full text

Disseminated Intravascular Coagulation and the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelets in Severe Preeclampsia

Peter A. van Dam, Marine Renier, M. Baekelandt et al. · Obstetric Anesthesia Digest · 1989 · 95 citations

Literary Theory, F. Author Information, Intravascular Coagulation +18

Clinical Significance of Apoptosis-Related Factors <i>p53</i>, <i>Mdm2</i>, and <i>Bcl-2</i> in Advanced Ovarian Cancer

M. Baekelandt, Gunnar B. Kristensen, J. M. Nesland et al. · Journal of Clinical Oncology · 1999 · 93 citations